Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Net Margin: 2017-2020

Historic Net Margin for Cogent Biosciences (COGT) over the last 4 years, with Sep 2020 value amounting to -18,325.64%.

  • Cogent Biosciences' Net Margin fell 1715672.00% to -18,325.64% in Q3 2020 from the same period last year, while for Sep 2020 it was -295.23%, marking a year-over-year increase of 9271.00%. This contributed to the annual value of -1,042.50% for FY2020, which is 90101.00% down from last year.
  • Per Cogent Biosciences' latest filing, its Net Margin stood at -18,325.64% for Q3 2020, which was down 1,207.56% from -1,401.52% recorded in Q2 2020.
  • Cogent Biosciences' 5-year Net Margin high stood at 15.02% for Q4 2019, and its period low was -18,325.64% during Q3 2020.
  • Over the past 3 years, Cogent Biosciences' median Net Margin value was -382.93% (recorded in 2019), while the average stood at -2,114.12%.
  • Data for Cogent Biosciences' Net Margin shows a peak YoY increase of 29,626bps (in 2020) and a maximum YoY decrease of 1,715,672bps (in 2020) over the last 5 years.
  • Quarterly analysis of 4 years shows Cogent Biosciences' Net Margin stood at -315.87% in 2017, then spiked by 8,970bps to -226.18% in 2018, then soared by 24,120bps to 15.02% in 2019, then slumped by 1,715,672bps to -18,325.64% in 2020.
  • Its Net Margin stands at -18,325.64% for Q3 2020, versus -1,401.52% for Q2 2020 and -86.67% for Q1 2020.